MP
DFTX

McDonald Partners’s Definium Therapeutics DFTX Stock Holding History

McDonald Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1K Buy
+66
New +$1.63K ﹤0.01% 561

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

McDonald Partners's DFTX Position: Q2 2026 in Review

McDonald Partners opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 66 shares worth $3.1K. The stake represents ﹤0.01% of the portfolio and ranks #561 among its holdings.

57 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • McDonald Partners held 66 shares of Definium Therapeutics worth $3.1K as of Q2 2026.
  • Definium Therapeutics was a new McDonald Partners position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of McDonald Partners's portfolio in Q2 2026, its #561 holding.
  • 57 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.